Excerise the fourth and final option year for the temazepam capsules BPA for the pharm repackaging program.

Ended Awarded Last action

Contract number
36E79718N0043
Awardee
Awarding agency
Obligated
$7,642

Award facts

Contract value 100% obligated
$7,641.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Everettville, WV 26505, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Modification to reduce the obligation amount for product not received delivery order 797D80043 -$8,402
Original award $16,044

Quick answers

Who was awarded contract 36E79718N0043?

36E79718N0043 was awarded to Mylan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on April 4, 2018.

How much is contract 36E79718N0043 worth?

The government has obligated $7,642 on 36E79718N0043.

Is contract 36E79718N0043 an order under another contract?

Yes. 36E79718N0043 is a BPA call under V797D30107-VA797P13A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79718N0043 competed?

The extent of competition for 36E79718N0043 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award